Clinical trials in urology are performed to try to find better, safer and more effective treatments for urological conditions and diseases.

These research studies are designed to answer specific medical questions while protecting the safety of research subjects. A well conducted clinical trial is the fastest and safest way to find better treatments and preventions for urological diseases.

Clinical trials are designed to reduce bias in the conduct of the study and interpretation of the results. In many cases the research subject and that Investigator both do not know which study treatment is being administered,  this is known as “blinding”. Placebos, or in active substances,  are normally given to a percentage of the research subjects in a given study to assist in the evaluation of the active investigational medication or product under study.

Study participants are often randomly assigned to receive either the active investigational medication (at one or more doses) or placebo in a process known as randomization, also to reduce bias.

Studies are conducted in accordance with a clinical trial protocol that states the rationale, objectives, statistical design and methodology of the study along with how the trial will be managed.

Research subjects are people who have consented to participate in a study through a process known as informed consent. During this process detailed information is provided both in writing and by speaking to research staff to ensure that all of the important information regarding what it means to participate in the study is provided and understood.